drugset / Trial / NCT00052286

Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer

NCT00052286

RandomizedParallel-groupTriple-blindSupportive care

Summary

RATIONALE: Modafinil may be effective in relieving fatigue and improving behavioral changes such as memory loss in patients who have undergone treatment for primary brain cancer. The effectiveness of modafinil in relieving fatigue and improving behavioral change is not yet known. PURPOSE: This randomized clinical trial is comparing how well two different doses of modafinil work in treating fatigue and behavioral changes in patients who have undergone treatment for primary brain cancer.

Timeline

Start
2002-09
Primary completion
2006-07
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Modafinil Small molecule Oral